The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Muhammed, Louwai, Dr
    Doctor born in December 1989
    Individual (3 offsprings)
    Officer
    2021-02-01 ~ now
    OF - Director → CIF 0
  • 2
    Laaniste, Liisi, Dr
    Scientist born in October 1987
    Individual (1 offspring)
    Officer
    2021-02-01 ~ now
    OF - Director → CIF 0
  • 3
    Cannon, Gillian
    Board Director born in November 1963
    Individual (1 offspring)
    Officer
    2024-07-22 ~ now
    OF - Director → CIF 0
Ceased 3
  • 1
    Dr Louwai Muhammed
    Born in December 1989
    Individual (3 offsprings)
    Person with significant control
    2021-02-01 ~ 2022-05-16
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Dr Liisi Laaniste
    Born in October 1987
    Individual (1 offspring)
    Person with significant control
    2021-02-01 ~ 2022-05-16
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 3
    Johnson, Michael, Professor
    Doctor born in April 1960
    Individual
    Officer
    2021-02-01 ~ 2023-05-19
    OF - Director → CIF 0
    Professor Michael Johnson
    Born in April 1960
    Individual
    Person with significant control
    2021-02-01 ~ 2022-05-16
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

COSYNE THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
172023-03-01 ~ 2024-02-29
82022-03-01 ~ 2023-02-28
Intangible Assets
221,117 GBP2024-02-29
66,944 GBP2023-02-28
Property, Plant & Equipment
75,520 GBP2024-02-29
27,608 GBP2023-02-28
Fixed Assets
296,637 GBP2024-02-29
94,552 GBP2023-02-28
Debtors
Current
621,154 GBP2024-02-29
158,929 GBP2023-02-28
Cash at bank and in hand
1,644,388 GBP2024-02-29
4,646,062 GBP2023-02-28
Current Assets
2,265,542 GBP2024-02-29
4,804,991 GBP2023-02-28
Creditors
Current, Amounts falling due within one year
-283,490 GBP2024-02-29
-77,878 GBP2023-02-28
Net Current Assets/Liabilities
1,982,052 GBP2024-02-29
4,727,113 GBP2023-02-28
Total Assets Less Current Liabilities
2,278,689 GBP2024-02-29
4,821,665 GBP2023-02-28
Net Assets/Liabilities
2,278,689 GBP2024-02-29
4,821,665 GBP2023-02-28
Equity
Called up share capital
54 GBP2024-02-29
53 GBP2023-02-28
Share premium
6,264,438 GBP2024-02-29
6,229,955 GBP2023-02-28
Retained earnings (accumulated losses)
-3,985,803 GBP2024-02-29
-1,408,343 GBP2023-02-28
Equity
2,278,689 GBP2024-02-29
4,821,665 GBP2023-02-28
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
214,555 GBP2024-02-29
59,575 GBP2023-02-28
Computer software
8,076 GBP2024-02-29
8,076 GBP2023-02-28
Intangible Assets - Gross Cost
222,631 GBP2024-02-29
67,651 GBP2023-02-28
Intangible Assets - Accumulated Amortisation & Impairment
1,514 GBP2024-02-29
707 GBP2023-02-28
Intangible Assets - Increase From Amortisation Charge for Year
807 GBP2023-03-01 ~ 2024-02-29
Intangible Assets
Patents/Trademarks/Licences/Concessions
214,555 GBP2024-02-29
59,575 GBP2023-02-28
Property, Plant & Equipment - Gross Cost
Office equipment
5,629 GBP2024-02-29
4,455 GBP2023-02-28
Computers
126,021 GBP2024-02-29
50,835 GBP2023-02-28
Property, Plant & Equipment - Gross Cost
131,650 GBP2024-02-29
55,290 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
1,661 GBP2023-02-28
Computers
26,021 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
27,682 GBP2023-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
2,265 GBP2023-03-01 ~ 2024-02-29
Computers, Owned/Freehold
26,183 GBP2023-03-01 ~ 2024-02-29
Owned/Freehold
28,448 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
3,926 GBP2024-02-29
Computers
52,204 GBP2024-02-29
Property, Plant & Equipment - Accumulated Depreciation & Impairment
56,130 GBP2024-02-29
Property, Plant & Equipment
Office equipment
1,703 GBP2024-02-29
2,794 GBP2023-02-28
Computers
73,817 GBP2024-02-29
24,814 GBP2023-02-28
Other Debtors
Current
153,772 GBP2024-02-29
107,639 GBP2023-02-28
Prepayments/Accrued Income
Current
57,813 GBP2024-02-29
51,290 GBP2023-02-28
Amount of corporation tax that is recoverable
Current
409,569 GBP2024-02-29
Bank Overdrafts
Current
6,517 GBP2024-02-29
Trade Creditors/Trade Payables
Current
225,868 GBP2024-02-29
69,689 GBP2023-02-28
Taxation/Social Security Payable
Current
1,561 GBP2024-02-29
Other Creditors
Current
8,138 GBP2024-02-29
2,779 GBP2023-02-28
Accrued Liabilities/Deferred Income
Current
41,406 GBP2024-02-29
5,410 GBP2023-02-28
Creditors
Current
283,490 GBP2024-02-29
77,878 GBP2023-02-28
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,444,171 shares2024-02-29
3,036,507 shares2023-02-28
Par Value of Share
Class 1 ordinary share
0.000012023-03-01 ~ 2024-02-29
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
2,268,703 shares2024-02-29
2,268,703 shares2023-02-28
Par Value of Share
Class 2 ordinary share
0.000012023-03-01 ~ 2024-02-29
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
688,125 shares2024-02-29
Par Value of Share
Class 3 ordinary share
0.000012023-03-01 ~ 2024-02-29
  • COSYNE THERAPEUTICS LIMITED
    Info
    Registered number 13171951
    2 Sheraton Street, Wework Medius House, London W1F 8BH
    Private Limited Company incorporated on 2021-02-01 (4 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-31
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.